论文部分内容阅读
目的观察奥扎格雷钠治疗急性脑梗死的临床效果。方法75例急性脑梗死患者随机分成两组,治疗组39例,对照组36例。治疗组用奥扎格雷钠80 mg加生理盐水250 ml静滴(1次/d);对照组给予维脑路通注射液400 mg加250 ml生理盐水静滴(1次/d),两组疗程均为3周。结果治疗组神经功能缺损程度评分改善优于对照组(P<0.05);治疗组总有效率为89.74%,明显高于对照组的83.3%(P<0.01)。结论本实验表明急性脑梗死患者用奥扎格雷钠治疗效果很好。
Objective To observe the clinical effect of ozagrel sodium on acute cerebral infarction. Methods 75 cases of acute cerebral infarction were randomly divided into two groups, the treatment group 39 cases, control group 36 cases. In the treatment group, sodium ozagrel 80 mg and normal saline 250 ml were intravenously administered once a day, while those in the control group were given 400 mg of venlaton-injection plus 250 ml normal saline once a day, The course of treatment is 3 weeks. Results The score of neurological impairment in the treatment group was better than that in the control group (P <0.05). The total effective rate in the treatment group was 89.74%, which was significantly higher than that in the control group (83.3%, P <0.01). Conclusion This experiment shows that patients with acute cerebral infarction treated with ozagrel sodium works well.